Remogliflozin Etabonate

Preferred Label : Remogliflozin Etabonate;

NCIt definition : An orally available prodrug of remogliflozin, a benzylpyrazole glucoside-based inhibitor of renal sodium-glucose co-transporter subtype 2 (SGLT2) with antihyperglycemic activity. Upon administration and absorption, the inactive prodrug is converted to its active form remogliflozin and acts selectively on the sodium-glucose co-transporter subtype 2 (SGLT2).;

UNII : TR0QT6QSUL;

InChIKey : UAOCLDQAQNNEAX-ABMICEGHSA-N;

CAS number : 442201-24-3;

Chemical formula : C26H38N2O9;

Details

Origin ID

C91023;

UMLS CUI

C2605528;

Currated CISMeF NLP mapping
- remogliflozin etabonate [MeSH concept]
- remogliflozin etabonate [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing remogliflozin etabonate (medicinal product) [SNOMED CT concept]
- Remogliflozin etabonate (substance) [SNOMED CT concept]
- remogliflozin etabonate [MeSH concept]
- remogliflozin etabonate [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients